Delivery Order SPE2DB22D3016-SPE2DB24FAJM8
Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,566,165,480 units of ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $22,056.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with a completion date of October 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of 4,567,227,090 units of 4 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,294.40 firm-fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 11, 2025, with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of 4,564,662,850 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,905.15 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of 4,566,790,448 units of Ondansetron HCL 4 mg tablets in 30-count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,713.75 and is a Firm Fixed Price Delivery Order type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of 4,566,698,076 units of Ondansetron ODT 4 MG Tablet 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,184.73 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,787.18, is for the delivery of 4,566,947,023 units of Ondansetron HCL 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $32,573.01 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 16, 2024. The contract has an ultimate completion date of September 17, 2024 and is not set aside for any specific business type. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award is for the delivery of 4,566,371,764 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,152.42 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,564,464,724 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $6,674.51. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of May 2, 2024. This award is not designated as a set-aside contract....
- This federal contract award is for the delivery of 4,566,518 units of Ondansetron HCl 4 mg tablets to the Defense Logistics Agency (DLA). The $5,596.44 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 21, 2024, with a completion date of November 22, 2024. The contract is a delivery order issued under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...